Testing effectiveness (Phase 2)Study completedNCT00200447
What this trial is testing
An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
Who this might be right for
Parkinson's Disease
Molecular NeuroImaging 3
Showing 20 of 0 results